Approval for the migration of the advia centaur cpsa assay to the atellica im system
Device | Atellica IM CPSA Assay |
Classification Name | Antigen(complexed),prostate Specific,(cpsa) |
Generic Name | Antigen(complexed),prostate Specific,(cpsa) |
Applicant | SIEMENS HEALTHCARE DIAGNOSTICS |
Date Received | 2017-09-29 |
Decision Date | 2018-08-03 |
PMA | P990055 |
Supplement | S016 |
Product Code | NAF |
Docket Number | Premarket Approval (PMA) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Links U.S. Food & Drug Administration Follow FDA En Español Search FDA Home Food Drugs Medical Devices Radia |
Advisory Committee | Immunology |
Supplement Type | Normal 180 Day Track |
Supplement Reason | Change Design/components/specifications/material |
Expedited Review | No |
Combination Product | No |
Applicant Address | SIEMENS HEALTHCARE DIAGNOSTICS 333 Coney Street walpole, MA 02032-1516 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P990055 | | Original Filing |
S024 |
2022-03-22 |
30-day Notice |
S023 |
2021-04-01 |
30-day Notice |
S022 |
2020-07-31 |
30-day Notice |
S021 |
2020-03-09 |
30-day Notice |
S020 |
2020-02-21 |
30-day Notice |
S019 | | |
S018 |
2019-02-01 |
30-day Notice |
S017 |
2018-07-27 |
Real-time Process |
S016 |
2017-09-29 |
Normal 180 Day Track |
S015 |
2015-05-07 |
Normal 180 Day Track |
S014 |
2012-03-26 |
Normal 180 Day Track No User Fee |
S013 |
2010-08-06 |
30-day Notice |
S012 |
2009-04-10 |
Normal 180 Day Track No User Fee |
S011 |
2009-02-06 |
30-day Notice |
S010 |
2009-03-06 |
Real-time Process |
S009 |
2006-05-17 |
Normal 180 Day Track No User Fee |
S008 |
2005-07-22 |
Real-time Process |
S007 |
2003-07-16 |
Real-time Process |
S006 |
2003-04-21 |
Real-time Process |
S005 |
2002-03-28 |
Normal 180 Day Track |
S004 |
2002-03-06 |
Normal 180 Day Track |
S003 |
2001-09-20 |
Normal 180 Day Track |
S002 |
2001-09-20 |
Normal 180 Day Track |
S001 |
2001-03-27 |
Normal 180 Day Track |
NIH GUDID Devices